Xianglin Shi's Location

Cambridge, MA, US

Xianglin Shi's Work

Xianglin Shi's Education

  • Emory University

    Ph.D. (organic chemistry, organometallics)

    1996 - 2000
  • Auburn Universty

    Master of Science - MS (Orgaic Chemistry, NMR)

    1994 - 1996
  • Shanghai Institute of Organic Chemistry, the Chinese Academy of Sciences

    Master of Science - MS (Natural products, organic synthesis)

Xianglin Shi's Skills

  • Science
  • Pharmaceutical Industry
  • Drug Discovery
  • Organic Synthesis
  • Technology Transfer
  • Biotechnology
  • Lc Ms
  • Medicinal Chemistry
  • Chemistry
  • Chromatography

Xianglin Shi's Summary

Xianglin Shi, based in Cambridge, MA, US, is currently a Chief Technology Officer at Leal Therapeutics, bringing experience from previous roles at Biogen and Takeda Oncology. Xianglin Shi holds a 1996 - 2000 Ph.D. in organic chemistry, organometallics @ Emory University. With a robust skill set that includes Science, Pharmaceutical Industry, Drug Discovery, Organic Synthesis, Technology Transfer and more, Xianglin Shi contributes valuable insights to the industry. Xianglin Shi has 3 emails on RocketReach.
Arrow

5 free lookups per month.
No credit card required.

If you need more lookups, subscriptions start at $48 USD/month.

Redirecting you to the search page.

If you're not automatically redirected, please click here

Not the Xianglin Shi you were looking for?

Find contact details for 700 million professionals.

Top Leal Therapeutics Employees

How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users